Increased fat mass and obesity risk after elexacaftor–tezacaftor–ivacaftor therapy in young adults with cystic fibrosis
After treatment with ETI, there was an increase in weight, BMI, and FM more than FFM in PwCF. These changes would be confirmed in long-term studies to improve nutritional management.
Authors
- David González Jiménez (ORCID: https://orcid.org/0000-0001-8696-9194)
- José Ramón Gutiérrez Martínez (ORCID: https://orcid.org/0000-0001-6724-6636)
- Saioa Vicente‐Santamaría (ORCID: https://orcid.org/0000-0003-2082-8983)
- Ana Merino Sánchez-Cañete
- María José Merino
- Concepción Marina López Cárdenes
- Marta Suárez González
Institutions
- Hospital Universitario Central de Asturias (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2024-11-07
- DOI
- https://doi.org/10.3389/fnut.2024.1477674
- Citations
- 8
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 3.35